NDC 71335-2007-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-2007
- Requested NDC
- 71335-2007-01
- Package NDCs from labels
- 71335-2007-1, 71335-2007-2, 71335-2007-3, 71335-2007-4, 71335-2007-5, 71335-2007-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-2007-1 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 103 | |
| 71335-2007-2 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 103 | |
| 71335-2007-3 | Levothyroxine sodium | 60 in 1 BOTTLE | TABLET | 60 | 103 | |
| 71335-2007-4 | Levothyroxine sodium | 18 in 1 BOTTLE | TABLET | 18 | 103 | |
| 71335-2007-5 | Levothyroxine sodium | 100 in 1 BOTTLE | TABLET | 100 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-2007 | LEVOTHYROXINE SODIUM TABLET [BRYANT RANCH PREPACK] | 103 | Current NDC, Legacy NDC, 5 package rows | 20241225_b57d0cc5-9fc7-496a-9bfa-417a288bb825.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dff641-ced3-bae3-e053-2a95a90a2e29 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 472ec9e7-c1db-bf8c-e063-6394a90a2c07 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Dem Zero | PHOSPHATIDYLSERINE, MAGNESIUM OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 411f1a0f-ed02-cc78-e063-6394a90a0aec | 2025-12-18 | Warnings | 3A3U0GI71G |
| Alzh L | PHOSPHATIDYLSERINE, MAGNESIUM OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 41056de0-aaa2-01bb-e063-6394a90af7b8 | 2025-12-18 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e3667ab1-2bd9-4e0d-8a97-f907593e7954 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | eb120047-a43b-40a4-9f55-067b1b51edda | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2adb05ef-b3fa-4ac2-b219-99442746392b | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d5b005e8-a88d-450b-bbc3-393d885260f5 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | c29a417b-95b0-4c9b-85e6-ec884049edb1 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3453af75-8c2e-421f-9a08-24751936df41 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1af49c9f-93da-4838-899b-9445083a154b | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fea284d8-0514-498b-a37c-405730b5f6a2 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Magnesium Oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc | 0bb322a5-fb92-14de-e063-6294a90a4c1b | 2025-11-14 | Warnings | 3A3U0GI71G |
| magnesium oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc. | dc57893c-068a-37d8-e053-2a95a90aa054 | 2025-11-14 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 4302e36f-0b5b-f645-e063-6394a90a010f | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | eb149423-070f-49ae-ab18-5afee09d06fb | 2025-11-02 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966221 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 48c29432-a36c-4787-a05f-8d25a0abcc37 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Magnesium Oxide | MAGNESIUM OXIDE | Kesin Pharma | 31f417f0-1637-eefa-e063-6294a90a121b | 2025-10-27 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Method Pharmaceuticals, LLC | 0af63651-f9d9-43b9-b6f0-4878466a82e6 | 2025-10-21 | Warnings | 3A3U0GI71G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Accord Healthcare Inc. | a6233381-3043-4e9a-aaa6-a6b105e5142b | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | ANDA212399 16729-452 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 415fc774-31a5-124f-e063-6294a90a0e46 a6233381-3043-4e9a-aaa6-a6b105e5142b 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.